Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC label comprehension studies need more "specific communication objectives" -- FDAer.

This article was originally published in The Tan Sheet

Executive Summary

OTC LABEL COMPREHENSION STUDIES WITH MORE "SPECIFIC COMMUNICATION OBJECTIVES" urged by FDA Chief of Marketing Practice and Communication Louis Morris, PhD, at the annual meeting of the Drug Information Association in San Diego June 9-13. "I think we need to work toward more specific planning of our tests," Morris suggested. FDA has "been pushing things we call `communication objectives,' and I think many companies have used them, but some have done so [using] very general terms," he said. "I'd like to see them move toward more specific terms."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085517

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel